Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMKOR TECHNOLOGY, INC.AMKR · Entity 3481 | Director | September 22, 2026 | September 24, 2026 |
| Baudax Bio, Inc.BXRX · Entity 109081 | Director | June 15, 2022 | June 17, 2022 |
| Lifeward Ltd.RWLK · Entity 7620 | 10% owner | June 26, 2017 | June 28, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMKOR TECHNOLOGY, INC.
Report date September 22, 2026 · Filed September 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,619.5144 |
Reported balance
After 2026-09-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-22 · Grant · Acquired 3.9978 · Balance 2,619.5144 F1: Represents dividend equivalent units ("DEUs") accrued upon the payment of a dividend on September 22, 2026 with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") granted to the Reporting Person on May 13, 2026. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent units ("DEUs") accrued upon the payment of a dividend on September 22, 2026 with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") granted to the Reporting Person on May 13, 2026. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued.
Baudax Bio, Inc.
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,820 |
Reported balance
After 2022-06-15 transaction · row 1
1 source rowRow 1 · 2022-06-15 · Grant · Acquired 39,473 · Balance 46,820 F1: Each Restricted Stock Unit ("RSU") is the economic equivalent of one share of Baudax Bio, Inc. (the "Company") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") is the economic equivalent of one share of Baudax Bio, Inc. (the "Company") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date.
Lifeward Ltd.
Report date June 26, 2017 · Filed June 28, 2017
Jointly reported with SCP Vitalife Partners (Israel) II, L.P., SCP Vitalife II Associates, L.P., SCP Vitalife II GP, Ltd., LUDOMIRSKI ABRAHAM
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 0.01 per shareSEC Table I · non-derivative | Direct | 339,900 |
Last balance in matching sequence
After 2017-06-27 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-06-26 · Sale · Disposed 9,271 · Balance 352,411 F1: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. Row 2 · 2017-06-27 · Sale · Disposed 12,511 · Balance 339,900 F1: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.
F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INNOVATIVE SOLUTIONS & SUPPORT INC
Report date June 13, 2023 · Filed June 14, 2023
Section 16 reporting ended · disclosed 2023-06-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,523 |
Reported balance
After 2023-06-13 transaction · row 1
1 source rowRow 1 · 2023-06-13 · Sale · Disposed 3,499 · Balance 9,523 |
Societal CDMO, Inc.
Report date April 08, 2024 · Filed April 09, 2024
Section 16 reporting ended · disclosed 2024-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-04-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-04-08 · Other · Disposed 227,982 · Balance 73,620 F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation ("Parent") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the "Effective Time") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the "Offer Amount"), subject to any applicable withholding taxes and without interest. Row 2 · 2024-04-08 · Disposition to issuer · Disposed 73,620 · Balance 0 F2: Represents restricted stock units granted under an Issuer equity plan ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 | Direct | 0 |
Reported balance
After 2024-04-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-08 · Disposition to issuer · Disposed 118,182 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an "Issuer Stock Option") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.74 | Direct | 0 |
Reported balance
After 2024-04-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-04-08 · Disposition to issuer · Disposed 27,229 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an "Issuer Stock Option") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation ("Parent") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the "Effective Time") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the "Offer Amount"), subject to any applicable withholding taxes and without interest.
F2: Represents restricted stock units granted under an Issuer equity plan ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes.
F3: Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an "Issuer Stock Option") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2023 Filed May 19, 2023 00:06 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionCommon Stock | 8,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030833 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 17, 2022, the Reporting Person was granted 8,706 time-vested restricted stock units ("RSUs") pursuant to the Amkor Technology, Inc. (the "Issuer") 2021 Equity Incentive Plan, as amended (the "Plan"), and the applicable award agreement (the "2022 RSUs"). In connection with the vesting of the 2022 RSUs on May 16, 2023: (i) 0.4075 of the 2022 RSUs, which had accrued as dividend equivalent units ("DEUs") with each DEU representing an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued, were settled in cash; and (ii) the remainder of the 2022 RSUs, including 103 DEUs, converted into common stock of the Issuer on a one-for-one basis. F1 · price: On May 17, 2022, the Reporting Person was granted 8,706 time-vested restricted stock units ("RSUs") pursuant to the Amkor Technology, Inc. (the "Issuer") 2021 Equity Incentive Plan, as amended (the "Plan"), and the applicable award agreement (the "2022 RSUs"). In connection with the vesting of the 2022 RSUs on May 16, 2023: (i) 0.4075 of the 2022 RSUs, which had accrued as dividend equivalent units ("DEUs") with each DEU representing an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued, were settled in cash; and (ii) the remainder of the 2022 RSUs, including 103 DEUs, converted into common stock of the Issuer on a one-for-one basis. F1 · balance_after: On May 17, 2022, the Reporting Person was granted 8,706 time-vested restricted stock units ("RSUs") pursuant to the Amkor Technology, Inc. (the "Issuer") 2021 Equity Incentive Plan, as amended (the "Plan"), and the applicable award agreement (the "2022 RSUs"). In connection with the vesting of the 2022 RSUs on May 16, 2023: (i) 0.4075 of the 2022 RSUs, which had accrued as dividend equivalent units ("DEUs") with each DEU representing an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued, were settled in cash; and (ii) the remainder of the 2022 RSUs, including 103 DEUs, converted into common stock of the Issuer on a one-for-one basis. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 21:19 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-047880 · tm2312625-2_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,872 F1 · security: A portion of the Reporting Person's stock based compensation for the year ended December 31, 2023. In connection with a previously disclosed stock grant on January 3, 2023, the Issuer's Board of Directors determined to make the annual issuance of stock-based compensation to its independent directors in April rather than in January going forward. This grant represents the Reporting Person's stock-based compensation for the period running from January 1, 2023 through April 18, 2023. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 22:37 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantRestricted Stock Units · Derivative | 26.1076 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-020613 · doc4.xml · derivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,809.4075 Underlying: Common Stock · 26.1076 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on March 20, 2023. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · shares: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on March 20, 2023. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on March 20, 2023. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on March 20, 2023. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.underlying_shares: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on March 20, 2023. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:04 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionDirector Stock Option (Right-to-Buy) · Derivative | 20,000 | $0.00 Strike: $8.51 | $0.00 |
DisclosureSEC source: 0001209191-23-010747 · doc4.xml · derivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2028-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This stock option to acquire 20,000 shares of the Issuer's common stock was granted on May 1, 2018 and vested in full on May 1, 2019. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:04 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | SaleCommon Stock | 20,000 | $27.29 | $545,800.00 |
DisclosureSEC source: 0001209191-23-010747 · doc4.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,394 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.27 to $27.35.The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:04 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionCommon Stock | 20,000 | $8.51 | $170,200.00 |
DisclosureSEC source: 0001209191-23-010747 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:34 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001451 · tm232195-2_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,130 F1 · security: Stock based compensation for the year ended December 31, 2022. In connection with this issuance, the Issuer's Board of Directors determined to make the annual issuance of stock-based compensation to its independent directors in April rather than in January for future periods. Read SEC document |
| December 27, 2022 Filed Dec 29, 2022 22:26 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantRestricted Stock Units · Derivative | 26.7602 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062931 · doc4.xml · derivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,783.2999 Underlying: Common Stock · 26.7602 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on December 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · shares: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on December 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on December 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on December 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.underlying_shares: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on December 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:03 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionDirector Stock Option (Right-to-Buy) · Derivative | 20,000 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0001209191-22-060522 · doc4.xml · derivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This stock option to acquire 20,000 shares of Amkor Technology, Inc. common stock was granted on May 13, 2014 and vested in full on March 5, 2015. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:03 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | SaleCommon Stock | 20,000 | $26.00 | $520,000.00 |
DisclosureSEC source: 0001209191-22-060522 · doc4.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,394 Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:03 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionCommon Stock | 20,000 | $9.17 | $183,400.00 |
DisclosureSEC source: 0001209191-22-060522 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 21:06 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantRestricted Stock Units · Derivative | 25.9881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051478 · doc4.xml · derivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,756.5397 Underlying: Common Stock · 25.9881 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on September 26, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · shares: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on September 26, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on September 26, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on September 26, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · derivative.underlying_shares: Represents dividend equivalent units ("DEUs") accrued with respect to time-vested restricted stock units ("RSUs") of Amkor Technology, Inc. (the "Issuer") upon the Issuer's payment of a dividend on September 26, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 23:53 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantRestricted Stock Units · Derivative | 24.5516 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039865 · doc4.xml · derivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,730.5516 Underlying: Common Stock · 24.5516 shares Expires not disclosed F2 · derivative.exercise_price: Represents DEUs accrued with respect to the RSUs upon the Issuer's payment of a dividend on June 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F2 · shares: Represents DEUs accrued with respect to the RSUs upon the Issuer's payment of a dividend on June 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F2 · derivative.exercise_date: Represents DEUs accrued with respect to the RSUs upon the Issuer's payment of a dividend on June 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F2 · derivative.expiration_date: Represents DEUs accrued with respect to the RSUs upon the Issuer's payment of a dividend on June 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F2 · derivative.underlying_shares: Represents DEUs accrued with respect to the RSUs upon the Issuer's payment of a dividend on June 27, 2022. Each DEU represents an additional RSU subject to the same provisions as the RSU with respect to which the DEU was accrued. F1 · balance_after: As previously reported in a Form 4 filed by the Reporting Person on May 19, 2022 (the "Original Form 4"), 8,706 shares of Amkor Technology, Inc. (the "Issuer") common stock underlying time-vested restricted stock units (the "RSUs") were granted to the Reporting Person on May 17, 2022. Pursuant to the award agreement for the RSUs, dividend equivalent units ("DEUs") accrue with respect to the RSUs when and as dividends are paid on the Issuer's common stock. In the Original Form 4, the RSUs were incorrectly reported in Table I. Table II, Column 9 of this Form 4 has been adjusted to include the RSUs and reflects the proper number of RSUs beneficially owned by the Reporting Person as of the filing date of this Form 4. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:12 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantCommon Stock | 39,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-015130 · form4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,820 F1 · shares: Each Restricted Stock Unit ("RSU") is the economic equivalent of one share of Baudax Bio, Inc. (the "Company") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:38 UTC | Societal CDMO, Inc. SCTL · Entity 92137 | GrantStock Option (right to buy) · Derivative | 118,182 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001062993-22-013176 · form4.xml · derivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,182 Underlying: Common Stock · 118,182 shares Expires 2032-05-18 F2 · derivative.exercise_date: The stock option will vest in full on May 18, 2023, subject to continued service with the Company. Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:38 UTC | Societal CDMO, Inc. SCTL · Entity 92137 | GrantCommon Stock | 87,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-013176 · form4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,482 F1 · price: These restricted stock units will vest in full on May 18, 2023, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 17, 2022 Filed May 19, 2022 21:19 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantCommon Stock | 8,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030644 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,100 F1 · shares: Represents shares of Amkor Technology, Inc. (the "Issuer") common stock underlying time-vested restricted stock units granted on May 17, 2022 (the "Grant Date") pursuant to the Issuer's Equity Incentive Plan (the "RSUs"). Subject to the terms and conditions of the applicable award agreement, the RSUs will vest in full on the earlier of the first anniversary of the Grant Date or the date of the Issuer's first annual meeting of the stockholders immediately following the Grant Date. The RSUs were awarded for no consideration other than the Reporting Person's service as a director of the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 23:19 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001050 · tm221460-3_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,042 F1 · security: Stock based compensation for the year ended December 31, 2021. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 22:22 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionDirector Stock Option (Right-to-Buy) · Derivative | 20,000 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-21-067313 · doc4.xml · derivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This stock option (the "Option") to acquire 20,000 shares of the Issuer's common stock (the "Option Shares") was granted on May 15, 2019 (the "Grant Date") and vested with respect to 100% of the Option Shares on the earlier of the the first anniversary of the Grant Date or the date of the first annual meeting of the Company immediately following the Grant Date. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 22:22 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | SaleCommon Stock | 20,000 | $22.42 | $448,400.00 |
DisclosureSEC source: 0001209191-21-067313 · doc4.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,394 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.40 to $22.47. The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 22:22 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionCommon Stock | 20,000 | $7.31 | $146,200.00 |
DisclosureSEC source: 0001209191-21-067313 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2021 Filed Aug 31, 2021 21:11 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | PurchaseCommon Stock | 100,000 | $0.63 | $62,930.00 |
DisclosureSEC source: 0001192482-21-000676 · edgar.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,185 Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:14 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | PurchaseCommon Stock | 10,000 | $0.78 | $7,848.00 |
DisclosureSEC source: 0001192482-21-000495 · edgar.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,185 Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:14 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | PurchaseCommon Stock | 15,000 | $0.78 | $11,661.00 |
DisclosureSEC source: 0001192482-21-000495 · edgar.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,185 Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:35 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 2,700 | $5.54 | $14,958.00 |
DisclosureSEC source: 0001104659-21-076410 · tm2118329-1_4seq1.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,693 Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:35 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 7,300 | $5.51 | $40,223.00 |
DisclosureSEC source: 0001104659-21-076410 · tm2118329-1_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,393 Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:13 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionDirector Stock Option (Right-to-Buy) · Derivative | 20,000 | $0.00 Strike: $9.83 | $0.00 |
DisclosureSEC source: 0001209191-21-035980 · doc4.xml · derivative · entry 4 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2031-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:13 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | SaleCommon Stock | 20,000 | $20.66 | $413,200.00 |
DisclosureSEC source: 0001209191-21-035980 · doc4.xml · nonDerivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,394 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.60 to $20.73. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:13 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | Exercise / conversionCommon Stock | 20,000 | $9.83 | $196,500.00 |
DisclosureSEC source: 0001209191-21-035980 · doc4.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:13 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | SaleCommon Stock | 6,106 | $20.67 | $126,211.02 |
DisclosureSEC source: 0001209191-21-035980 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,394 F1 · shares: These are restricted shares which were granted on May 19, 2020 and vested on May 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.60 to $20.72. Read SEC document |
| May 18, 2021 Filed May 19, 2021 21:28 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantDirector Stock Option (Right-to-Buy) · Derivative | 20,000 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-21-034075 · doc4.xml · derivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-18 F2 · derivative.exercise_date: These options vest 100% on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date. Read SEC document |
| May 18, 2021 Filed May 19, 2021 21:28 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantCommon Stock | 3,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034075 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 F1 · shares: These are restricted shares which vest 100% on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 21:56 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantStock Option (right to buy) · Derivative | 38,012 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001192482-21-000349 · edgar.xml · derivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,012 Underlying: Common Stock · 38,012 shares Expires 2031-04-20 F2 · derivative.exercise_date: The stock option will vest on April 20, 2022. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 21:56 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 26,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000349 · edgar.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,982 F1 · shares: All shares of common stock are represented by unvested restricted stock units that will vest on April 20, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date. Read SEC document |
| April 20, 2021 Filed May 17, 2021 20:09 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | GrantStock Option (right to buy) · Derivative | 38,012 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001192482-21-000435 · edgar.xml · derivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,012 Underlying: Common Stock · 38,012 shares Expires 2031-04-20 F1 · derivative.exercise_price: This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021. F2 · derivative.exercise_date: The stock option will vest on April 20, 2022. Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 23:08 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantStock Option (right to buy) · Derivative | 83,333 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001192482-21-000329 · edgar.xml · derivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires 2031-04-07 F2 · derivative.exercise_date: The stock option will vest on April 7, 2022. Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 23:08 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantCommon Stock | 56,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000329 · edgar.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,185 F1 · shares: All shares of common stock are represented by unvested restricted stock units that will vest on April 7, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:43 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 24,936 | $6.01 | $149,865.36 |
DisclosureSEC source: 0001104659-21-035108 · tm217565-8_4seq1.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,693 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:43 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 200 | $6.36 | $1,272.00 |
DisclosureSEC source: 0001104659-21-035108 · tm217565-8_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,629 Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 21:38 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | SaleCommon Stock | 8,207 | $24.21 | $198,691.47 |
DisclosureSEC source: 0001209191-21-010764 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,406 F1 · shares: These are restricted shares which were granted on May 15, 2019 and vested on May 15, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.20 to $24.22. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:32 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-001544 · tm211837-3_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,829 F1 · security: Stock based compensation for the year ended December 31, 2020. Read SEC document |
| December 17, 2020 Filed Dec 17, 2020 21:47 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 15,202 | $7.76 | $117,908.23 |
DisclosureSEC source: 0001104659-20-136904 · tm2038256d2_4seq1.xml · nonDerivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,957 Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:47 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,400 | $7.76 | $10,861.48 |
DisclosureSEC source: 0001104659-20-136904 · tm2038256d2_4seq1.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,159 Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:47 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 10,251 | $7.99 | $81,883.96 |
DisclosureSEC source: 0001104659-20-136904 · tm2038256d2_4seq1.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,559 Read SEC document |
| May 27, 2020 Filed May 27, 2020 21:20 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 3,673 | $5.03 | $18,481.07 |
DisclosureSEC source: 0001104659-20-066502 · a4.xml · nonDerivative · entry 4 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,810 Read SEC document |
| May 26, 2020 Filed May 27, 2020 21:20 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 14,327 | $5.04 | $72,190.89 |
DisclosureSEC source: 0001104659-20-066502 · a4.xml · nonDerivative · entry 3 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,483 Read SEC document |
| May 22, 2020 Filed May 27, 2020 21:20 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,700 | $5.03 | $8,549.98 |
DisclosureSEC source: 0001104659-20-066502 · a4.xml · nonDerivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,810 Read SEC document |
| May 21, 2020 Filed May 27, 2020 21:20 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 300 | $5.00 | $1,500.99 |
DisclosureSEC source: 0001104659-20-066502 · a4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,510 Read SEC document |
| May 19, 2020 Filed May 20, 2020 19:57 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantDirector Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.83 | $0.00 |
DisclosureSEC source: 0001209191-20-030850 · doc4.xml · derivative · entry 2 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2020-05-19 F2 · derivative.exercise_date: These options vest 100% on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date. Read SEC document |
| May 19, 2020 Filed May 20, 2020 19:57 UTC | AMKOR TECHNOLOGY, INC. AMKR · Entity 3481 | GrantCommon Stock | 6,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030850 · doc4.xml · nonDerivative · entry 1 CHURCHILL WINSTON J · CIK 0000923792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,613 F1 · shares: These are restricted shares which vest 100% on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.